H2020Individual fellowship2019–2021

anti-CRISPR · Selection and evolution of phage-encoded anti-CRISPR genes

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2019-05-01 → 2021-04-30
EU contribution
€224,934
Participants
1
Scheme
MSCA-IF

Lines connect the coordinator with its partners.

Results in brief

Selection and evolution of phage-encoded anti-CRISPR genes

The bacterial adaptive immune systems CRISPR-Cas are of pivotal importance in nature where they protect bacteria against their viral predators (phages). In response, some phages evolved a sophisticated strategy by encoding anti-CRISPR proteins (Acrs). While our molecular understanding of Acr mechanisms has raced ahead, a fundamental question remains unexplored: what is the impact of acr genes on the ecological and evolutionary dynamics of phages and their hosts? This research project explored the costs and benefits associated with Acrs, their consequences on the composition and evolution of phage populations as well as on the evolution of their host. The main results of this project are important for society as they can be implemented in biomedical research, for the development of phage therapy to combat antibiotic-resistant bacteria, as well as in biotechnologies for a better control of Cas9-based genome editing. The research objectives of this project were the following: 1) Determine when Acrs are beneficial. Despite their potential benefits for phage survival, acr genes are absent from many phage genomes and they have been more frequently found in temperate phages (i.e. phages that have the ability to lying dormant into host genome), which suggests that their benefits may be dependent on phage genetic background. 2) Examine how Acrs impact the dynamics of phage communities. Our previous work showed that Acr-phages need to cooperate to bypass CRISPR-based resistance: a first Acr-phage enters the cell and shuts-off the CRISPR immune system, although this process is not rapid enough to go through the infection process successfully. This “sacrifice” allows a second Acr-phage to take over the immunosuppressed cell, produce progeny and kill the host. However, in nature, phage populations are often not clonal and composed of mixed genotypes, with some that encode Acrs and some that do not. Since Acr-phages generate hosts with weakened immunity, we speculate they may enable other phages to infect bacteria with CRISPR-Cas defences. 3) Explore how Acrs impact the evolution of bacteria. Because they block some of the Cas proteins that mediate immunity acquisition, Acrs may affect the emergence of CRISPR-based resistance and this may have consequences on the evolutionary dynamics of bacteria. These research questions were studied with a multidisciplinary approach that combined phage molecular biology, experimental evolution and mathematical modelling in the group of Prof. Westra (University of Exeter, UK).

Data: CORDIS, © European Union

Project objective

CRISPR-Cas immune systems protect bacteria against their viruses (phage). However, some phages encode anti-CRISPR (Acr) genes that block CRISPR-Cas activity. While the molecular understanding of Acr activities and structures are racing ahead, their impact on the ecology and evolution of phage/bacteria populations remains unexplored.I first aim to identify the ecological factors that influence the selection for Acr genes, to explain why some phages encode many Acr whereas most encode none. Next, by running long-term co-culture experiments, I will examine whether CRISPR-Cas can evolve to escape Acr inhibition and whether Acr genes can reciprocally adapt to restore activity. These experiments will reveal how CRISPR-Cas and Acr coevolve and allow to mathematically predict the long-term stability of Acr activity. I will also explore the genetic bases of this coevolution through deep-sequencing analyses.This multidisciplinary project combines my expertise in phage biology, that of the host in experimental evolution and bioinformatics and that of collaborator in mathematical modelling. It is expected to open new avenues of research for downstream medical and bioengineering applications. This high-quality 'training-through-research' will allow me to widen my scientific expertise, develop essential complementary skills and constitute an international collaborative network. The visibility and impact of this research will be increased by a strong dissemination and communication plan. I also aim to reinforce my public engagement activities with a dual objective of making science accessible for everyone and inform about phage research. Carrying out this project within the Centre for Ecology and Conservation at the University of Exeter (EU accredited), a top department in ecology and evolution worldwide, and under the supervision of two world leading scientists in their fields, will be crucial for the development of my career as an independent European researcher.

Original text from CORDIS.

Participants

Links

Data: CORDIS, © European Union